Cart
sales@molnova.com
Peptide YY (13-36) (canine, mouse, porcine, rat)
CAS No. 86895-09-2
Peptide YY (13-36) (canine, mouse, porcine, rat)( ——— )
Catalog No. M40065 CAS No. 86895-09-2
Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePeptide YY (13-36) (canine, mouse, porcine, rat)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPeptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.
-
DescriptionPeptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number86895-09-2
-
Formula Weight3014.4
-
Molecular FormulaC135H209N41O38
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. D A Keire, et al. Primary structures of PYY, Pro(34)PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G126-31.?
molnova catalog
related products
-
Methyl nicotinate
Methyl nicotinate is the methyl ester of that is used as an active ingredient as a rubefacient in over-the-counter topical preparations indicated for muscle and joint pain.?The action of methyl nicotinate as a rubefacient is thought to involve peripheral vasodilation.
-
Ethyl docosanoate
Ethyl docosanoate (Ethyl behenate) is a component of honey aroma.
-
Opnurasib
Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.
